259 related articles for article (PubMed ID: 25655386)
1. Enhancing tumor-specific intracellular delivering efficiency of cell-penetrating peptide by fusion with a peptide targeting to EGFR.
Nguyen LT; Yang XZ; Du X; Wang JW; Zhang R; Zhao J; Wang FJ; Dong Y; Li PF
Amino Acids; 2015 May; 47(5):997-1006. PubMed ID: 25655386
[TBL] [Abstract][Full Text] [Related]
2. The heparin-binding domain of HB-EGF as an efficient cell-penetrating peptide for drug delivery.
Luo Z; Cao XW; Li C; Wu MD; Yang XZ; Zhao J; Wang FJ
J Pept Sci; 2016 Nov; 22(11-12):689-699. PubMed ID: 27739168
[TBL] [Abstract][Full Text] [Related]
3. Structure optimisation to improve the delivery efficiency and cell selectivity of a tumour-targeting cell-penetrating peptide.
Cao XW; Yang XZ; Du X; Fu LY; Zhang TZ; Shan HW; Zhao J; Wang FJ
J Drug Target; 2018 Nov; 26(9):777-792. PubMed ID: 29303375
[TBL] [Abstract][Full Text] [Related]
4. A novel cell-penetrating peptide derived from human eosinophil cationic protein.
Fang SL; Fan TC; Fu HW; Chen CJ; Hwang CS; Hung TJ; Lin LY; Chang MD
PLoS One; 2013; 8(3):e57318. PubMed ID: 23469189
[TBL] [Abstract][Full Text] [Related]
5. Improved breast cancer cell-specific intracellular drug delivery and therapeutic efficacy by coupling decoration with cell penetrating peptide and SP90 peptide.
Fan LQ; Du GX; Li PF; Li MW; Sun Y; Zhao LM
Biomed Pharmacother; 2016 Dec; 84():1783-1791. PubMed ID: 27899251
[TBL] [Abstract][Full Text] [Related]
6. Expression of Cell-Penetrating Peptides Fused to Protein Cargo.
Adhikari S; Alahmadi TI; Gong Z; Karlsson AJ
J Mol Microbiol Biotechnol; 2018; 28(4):159-168. PubMed ID: 30566948
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.
Gautam A; Sharma M; Vir P; Chaudhary K; Kapoor P; Kumar R; Nath SK; Raghava GP
Eur J Pharm Biopharm; 2015 Jan; 89():93-106. PubMed ID: 25459448
[TBL] [Abstract][Full Text] [Related]
8. A novel cell-penetrating peptide to facilitate intercellular transport of fused proteins.
Shen Y; Nagpal P; Hay JG; Sauthoff H
J Control Release; 2014 Aug; 188():44-52. PubMed ID: 24928321
[TBL] [Abstract][Full Text] [Related]
9. Design and screening of a glial cell-specific, cell penetrating peptide for therapeutic applications in multiple sclerosis.
Heffernan C; Sumer H; Guillemin GJ; Manuelpillai U; Verma PJ
PLoS One; 2012; 7(9):e45501. PubMed ID: 23049807
[TBL] [Abstract][Full Text] [Related]
10. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
Reissmann S
J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
[TBL] [Abstract][Full Text] [Related]
11. Simple and Efficient Purification of Recombinant Proteins Using the Heparin-Binding Affinity Tag.
Jayanthi S; Gundampati RK; Kumar TKS
Curr Protoc Protein Sci; 2017 Nov; 90():6.16.1-6.16.13. PubMed ID: 29091276
[TBL] [Abstract][Full Text] [Related]
12. Recombinant peptide constructs for targeted cell penetrating peptide-mediated delivery.
Zaro JL; Fei L; Shen WC
J Control Release; 2012 Mar; 158(3):357-61. PubMed ID: 22326404
[TBL] [Abstract][Full Text] [Related]
13. Expression, purification, and breast cancer cell inhibiting effect of recombinant human lactoferrin C-lobe.
Hu L; Gao CH; Hong C; Zhong Q; Dong HL; Gao XM
Biosci Biotechnol Biochem; 2016; 80(2):257-63. PubMed ID: 26405758
[TBL] [Abstract][Full Text] [Related]
14. Cellular internalization mechanism and intracellular trafficking of filamentous M13 phages displaying a cell-penetrating transbody and TAT peptide.
Kim A; Shin TH; Shin SM; Pham CD; Choi DK; Kwon MH; Kim YS
PLoS One; 2012; 7(12):e51813. PubMed ID: 23251631
[TBL] [Abstract][Full Text] [Related]
15. Targeting human epidermal growth factor receptor 2 by a cell-penetrating peptide-affibody bioconjugate.
Govindarajan S; Sivakumar J; Garimidi P; Rangaraj N; Kumar JM; Rao NM; Gopal V
Biomaterials; 2012 Mar; 33(8):2570-82. PubMed ID: 22192536
[TBL] [Abstract][Full Text] [Related]
16. Design and implementation of a high yield production system for recombinant expression of peptides.
Rodríguez V; Asenjo JA; Andrews BA
Microb Cell Fact; 2014 May; 13():65. PubMed ID: 24885242
[TBL] [Abstract][Full Text] [Related]
17. Internalization routes of cell-penetrating melanoma antigen peptides into human dendritic cells.
Buhl T; Braun A; Forkel S; Möbius W; van Werven L; Jahn O; Rezaei-Ghaleh N; Zweckstetter M; Mempel M; Schön MP; Haenssle HA
Exp Dermatol; 2014 Jan; 23(1):20-6. PubMed ID: 24372650
[TBL] [Abstract][Full Text] [Related]
18. Efficient drug delivery by novel cell-penetrating peptide derived from Midkine, with two heparin binding sites braced by a length-specific helix.
Chen Y; Li S; Zhao J; Cao X; Wang F
J Drug Target; 2022 Mar; 30(3):326-333. PubMed ID: 34708678
[TBL] [Abstract][Full Text] [Related]
19. Targeting tumor cells via EGF receptors: selective toxicity of an HBEGF-toxin fusion protein.
Chandler LA; Sosnowski BA; McDonald JR; Price JE; Aukerman SL; Baird A; Pierce GF; Houston LL
Int J Cancer; 1998 Sep; 78(1):106-11. PubMed ID: 9724101
[TBL] [Abstract][Full Text] [Related]
20. Protein cargo delivery properties of cell-penetrating peptides. A comparative study.
Säälik P; Elmquist A; Hansen M; Padari K; Saar K; Viht K; Langel U; Pooga M
Bioconjug Chem; 2004; 15(6):1246-53. PubMed ID: 15546190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]